Nasdaq

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Joplin Globe

Bayer’s Receives FDA Clearance for MEDRAD® Centargo CT Injection System

Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...
PharmiWeb

Bayer receives FDA clearance for expanded use of MEDRAD® Stellant FLEX CT Injection System in Contrast Enhanced Mammography (CEM)

INDIANOLA, Pa., Dec. 19, 2019 /PRNewswire/ -- Bayer announced today the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indication of its MEDRAD ® ...
Seeking Alpha

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...